Schedule 13G ownership disclosure

BIOCRYST PHARMACEUTICALS INC

Common Stock, $0.01 par value per share · CUSIP: 09058V103

Event date: 2025-11-04

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • RA Capital Management, L.P.

    Shares: 15,302,186.00 · Class: 7.3%

  • Peter Kolchinsky

    Shares: 15,302,186.00 · Class: 7.3%

  • Rajeev Shah

    Shares: 15,302,186.00 · Class: 7.3%

  • RA Capital Healthcare Fund, L.P.

    Shares: 15,302,186.00 · Class: 7.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001346824-25-000052
Form type
SCHEDULE 13G
Filer
BIOCRYST PHARMACEUTICALS INC
CIK
CIK 882796
Filed
Nov 12, 2025
Reporting period
Nov 04, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub